Skip to main content
. 2020 Feb 28;9(9):2997–3005. doi: 10.1002/cam4.2951

Table 1.

Patient characteristics at the time of recurrence before and after PSM

Variables Before matching After matching
RFA (n = 194) RHR (n = 138) P RFA (n = 120) RHR (n = 120) P
Age, y 52.9 ± 11.8 50.1 ± 10.9 .028 50.9 ± 11.6 50.3 ± 10.5 .683
Male sex 172 (88.7) 124 (89.9) .730 104 (86.7) 108 (90.0) .421
Hepatitis
HBV 172 (88.7) 126 (91.3) .725 108 (90.0) 112 (93.3) .582
HCV 6 (3.1) 3 (2.2) 2 (1.7) 2 (1.7)
Others 16 (8.2) 9 (6.5) 10 (8.3) 6 (5.0)
WBC, 109/L 6.4 ± 1.8 6.4 ± 1.8 .773 6.2 ± 1.7 6.3 ± 1.9 .600
PLT, 109/L 166.0 ± 57.3 176.0 ± 64.8 .138 162.2 ± 57.3 172.8 ± 65.5 .187
ALT, U/L 55.0 ± 87.4 54.1 ± 137.8 .942 60.3 ± 108.3 56.0 ± 147.1 .794
ALB, g/L 41.8 ± 4.6 42.5 ± 3.6 .176 42.0 ± 3.6 42.3 ± 3.6 .428
TBIL, μmol/L 15.3 ± 8.9 14.9 ± 5.8 .666 15.1 ± 8.5 15.0 ± 5.9 .911
AFP at recurrence, ng/mL
>20 71 (36.6) 43 (31.2) .304 50 (41.7) 45 (37.5) .509
≤20 123 (63.4) 95 (68.8) 70 (58.3) 75 (62.5)
Child‐Pugh score at recurrence
5 184 (94.8) 136 (98.6) .138 117 (97.5) 119 (99.2) .313
6 10 (5.2) 2 (1.4) 3 (2.5) 1 (0.8)
Cirrhosis 134 (69.1) 96 (69.6) .924 85 (70.8) 86 (71.7) .887
Time to recurrence
>2 y 67 (34.5) 84 (60.9) <.001 58 (48.3) 73 (60.8) .052
≤2 y 127 (65.5) 54 (39.1) 62 (51.7) 47 (39.2)
Tumor size at recurrence, cm 1.9 ± 0.9 2.8 ± 1.9 <.001 2.2 ± 1.0 2.4 ± 1.1 .091
Tumor number at recurrence
Solitary 162 (83.5) 112 (81.2) .579 106 (88.3) 106 (88.3) 1.000
Multiple 32 (16.5) 26 (18.8) 14 (11.7) 14 (11.7)

Variables are expressed as the mean ± SD or n (%).

Abbreviations: AFP, α‐fetoprotein; ALB, albumin; ALT, alanine aminotransferase; PLT, platelet; PSM, propensity score matching; RFA, radiofrequency ablation; RHR, repeat hepatic resection; TBIL, total bilirubin; WBC, white blood cell.